BHC Stock Overview
Bausch Health Companies Inc. operates as a diversified specialty pharmaceutical and medical device company in the United States and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 3/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
Bausch Health Companies Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$11.84 |
| 52 Week High | US$15.43 |
| 52 Week Low | US$7.56 |
| Beta | 0.86 |
| 1 Month Change | -8.50% |
| 3 Month Change | 8.23% |
| 1 Year Change | 14.29% |
| 3 Year Change | -67.88% |
| 5 Year Change | -63.03% |
| Change since IPO | 1,859.71% |
Recent News & Updates
Recent updates
Shareholder Returns
| BHC | CA Pharmaceuticals | CA Market | |
|---|---|---|---|
| 7D | -3.6% | -3.6% | -2.1% |
| 1Y | 14.3% | 58.0% | 3.6% |
Return vs Industry: BHC underperformed the Canadian Pharmaceuticals industry which returned 58% over the past year.
Return vs Market: BHC exceeded the Canadian Market which returned 3.6% over the past year.
Price Volatility
| BHC volatility | |
|---|---|
| BHC Average Weekly Movement | 5.4% |
| Pharmaceuticals Industry Average Movement | 14.2% |
| Market Average Movement | 9.2% |
| 10% most volatile stocks in CA Market | 18.4% |
| 10% least volatile stocks in CA Market | 3.1% |
Stable Share Price: BHC has not had significant price volatility in the past 3 months.
Volatility Over Time: BHC's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | 20,270 | Tom Appio | www.bauschhealth.com |
Bausch Health Companies Inc. operates as a diversified specialty pharmaceutical and medical device company in the United States and internationally. It develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, international pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health. The company operates through five segments: Salix, International, Solta Medical, Diversified, and Bausch + Lomb.
Bausch Health Companies Inc. Fundamentals Summary
| BHC fundamental statistics | |
|---|---|
| Market cap | CA$4.34b |
| Earnings (TTM) | -CA$815.07m |
| Revenue (TTM) | CA$12.06b |
0.4x
P/S Ratio-5.3x
P/E RatioIs BHC overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| BHC income statement (TTM) | |
|---|---|
| Revenue | US$8.76b |
| Cost of Revenue | US$2.56b |
| Gross Profit | US$6.20b |
| Other Expenses | US$6.79b |
| Earnings | -US$592.00m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
May 02, 2024
| Earnings per share (EPS) | -1.61 |
| Gross Margin | 70.78% |
| Net Profit Margin | -6.76% |
| Debt/Equity Ratio | -27,302.4% |
How did BHC perform over the long term?
See historical performance and comparison